New York State Common Retirement Fund Boosts Holdings in Xometry, Inc. (NASDAQ:XMTR)

New York State Common Retirement Fund increased its holdings in Xometry, Inc. (NASDAQ:XMTR - Free Report) by 9.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,093,862 shares of the company's stock after buying an additional 94,436 shares during the quarter. New York State Common Retirement Fund owned 2.41% of Xometry worth $39,281,000 at the end of the most recent reporting period.

Other large investors also recently added to or reduced their stakes in the company. J.P. Morgan Private Wealth Advisors LLC bought a new stake in shares of Xometry during the 3rd quarter valued at $180,000. Dark Forest Capital Management LP bought a new stake in shares of Xometry during the 3rd quarter valued at $220,000. Zurcher Kantonalbank Zurich Cantonalbank grew its position in shares of Xometry by 13.7% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,401 shares of the company's stock valued at $266,000 after acquiring an additional 894 shares during the period. Nisa Investment Advisors LLC grew its position in shares of Xometry by 50,118.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 8,035 shares of the company's stock valued at $289,000 after acquiring an additional 8,019 shares during the period. Finally, Graham Capital Management L.P. bought a new stake in shares of Xometry during the 3rd quarter valued at $332,000. 97.31% of the stock is currently owned by institutional investors.

Xometry Price Performance

Shares of XMTR traded up $0.03 during midday trading on Thursday, hitting $16.92. 443,399 shares of the company traded hands, compared to its average volume of 653,542. The firm has a 50 day moving average of $19.97 and a 200-day moving average of $23.75. Xometry, Inc. has a 52 week low of $12.45 and a 52 week high of $38.74. The stock has a market cap of $821.97 million, a price-to-earnings ratio of -12.06 and a beta of 0.71. The company has a debt-to-equity ratio of 0.85, a quick ratio of 4.25 and a current ratio of 4.28.


Xometry (NASDAQ:XMTR - Get Free Report) last released its quarterly earnings data on Thursday, February 29th. The company reported ($0.13) EPS for the quarter, missing the consensus estimate of ($0.12) by ($0.01). Xometry had a negative net margin of 14.56% and a negative return on equity of 17.34%. The company had revenue of $128.15 million for the quarter, compared to the consensus estimate of $127.78 million. On average, analysts forecast that Xometry, Inc. will post -0.64 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on XMTR. TheStreet downgraded shares of Xometry from a "c-" rating to a "d" rating in a research report on Thursday, February 29th. JMP Securities reiterated a "market outperform" rating and issued a $30.00 price target on shares of Xometry in a research note on Tuesday. UBS Group cut their price target on Xometry from $22.00 to $21.00 and set a "neutral" rating for the company in a research note on Wednesday, March 13th. The Goldman Sachs Group cut their price target on Xometry from $46.00 to $28.00 and set a "buy" rating for the company in a research note on Friday, March 1st. Finally, Royal Bank of Canada cut their price target on Xometry from $38.00 to $23.00 and set a "sector perform" rating for the company in a research note on Friday, March 1st. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $26.67.

Get Our Latest Research Report on XMTR

Insider Activity at Xometry

In related news, Director Emily Rollins sold 1,000 shares of the stock in a transaction dated Friday, January 26th. The shares were sold at an average price of $32.39, for a total value of $32,390.00. Following the completion of the transaction, the director now owns 10,770 shares of the company's stock, valued at approximately $348,840.30. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, COO Peter Goguen sold 3,943 shares of the stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $17.61, for a total value of $69,436.23. Following the completion of the transaction, the chief operating officer now owns 197,211 shares of the company's stock, valued at approximately $3,472,885.71. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Emily Rollins sold 1,000 shares of the firm's stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $32.39, for a total transaction of $32,390.00. Following the completion of the sale, the director now directly owns 10,770 shares of the company's stock, valued at approximately $348,840.30. The disclosure for this sale can be found here. In the last quarter, insiders sold 11,243 shares of company stock valued at $279,642. Insiders own 19.23% of the company's stock.

Xometry Company Profile

(Free Report)

Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.

Further Reading

Institutional Ownership by Quarter for Xometry (NASDAQ:XMTR)

→ Gold Mania (From Stansberry Research) (Ad)

Should you invest $1,000 in Xometry right now?

Before you consider Xometry, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xometry wasn't on the list.

While Xometry currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Featured Articles and Offers

Search Headlines: